Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Managing Business Risks During a Merger or Acquisition

October 2, 2011

Pharmaceutical Technology

Getting the most value out of M&As requires proper upfront legwork.

Sizing Up the Global Market for Excipients

October 2, 2011

Pharmaceutical Technology

The global excipients market shows moderate growth, increased consolidation, and expansion activity in emerging markets and select product areas.

Q&A with Rao Tatapudy, Catalent

October 2, 2011
Pharmaceutical Technology

A Q&A with Rao Tatapudy, vice-president of scientific affairs at Catalent, on recent industry trends.

Quality Issues for Multiregional Clinical-Trial Materials

October 2, 2011

Pharmaceutical Technology

The authors examine risk management relating to the quality issues of clinical-trial materials and discuss areas that would benefit from additional consideration and harmonization.

Time is of the Essence

October 2, 2011

Pharmaceutical Technology

Letting contamination build up can cause multiple headaches.

Inside PIC/S: The Importance of PIC/S in a Globalized World

October 2, 2011

Pharmaceutical Technology

Expanding the organization's mandate will strengthen inspections.

Pfizer Outlines Its Supply Strategy

October 2, 2011

Pharmaceutical Technology

John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.

Preparing for the Last War

October 2, 2011

Pharmaceutical Technology

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.

Report from India

October 2, 2011

Pharmaceutical Technology

In an effort to balance bilateral trade, India is urging China to increase Indian pharmaceutical imports.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here